Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype.

Autor: Adams P; University Hospital, Western University, London, ON, Canada., Altes A; Asociación Española de Hemocromatosis, Santa Coloma, Spain., Brissot P; Inserm Unit 1241, University Hospital Pontchaillou, Rennes, France. pierre.brissot@univ-rennes1.fr.; HI - Haemochromatosis International, London, UK. pierre.brissot@univ-rennes1.fr., Butzeck B; HI - Haemochromatosis International, London, UK.; European Federation of Associations of Patients with Haemochromatosis, Seine, France.; Haemochromatose-Vereinigung Deutschland, Hürth, Germany., Cabantchik I; International Bioiron Society, Schaumburg, USA.; Hebrew University of Jerusalem, Jerusalem, Israel., Cançado R; Division of Hematology, Santa Casa Medical School of Sao Paulo, Sao Paulo, SP, Brazil., Distante S; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Evans P; HI - Haemochromatosis International, London, UK.; European Federation of Associations of Patients with Haemochromatosis, Seine, France., Evans R; HI - Haemochromatosis International, London, UK.; Department of Electronic and Computer Engineering, School of Engineering and Design, Brunel University, Uxbridge, UK.; The Haemochromatosis Society, Hertfordshire, UK., Ganz T; David Geffen School of Medicine, UCLA, Los Angeles, CA, USA., Girelli D; Department of Medicine, University of Verona Veneto Region Referral Center for Iron Metabolism Disorders, Verona, Italy., Hultcrantz R; Department of Medicine, Unit of Gastroenterology and Rheumatology, Karolinska Institutet, Stockholm, Sweden., McLaren G; Division of Hematology/Oncology, University of California, Irvine, CA, USA., Marris B; HI - Haemochromatosis International, London, UK.; Haemochromatosis Australia, Meridan Plains, Australia., Milman N; Danish Haemochromatosis Association, Copenhagen, Denmark., Nemeth E; Center for Iron Disorders, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA., Nielsen P; Institut für Biochemie und Molekulare Zellbiologie, University Medical Center Hamburg, Hamburg, Germany., Pineau B; Fédération Française des Associations de Malades de l'hémochromatose, Paris, France., Piperno A; Department of Medicine and Surgery, Centre for Rare Diseases, University of Milano-Bicocca, Monza, Italy.; Association for the Study of Hemochromatosis and Iron Overload Diseases, Monza, Italy., Porto G; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; CHP-HSA - Centro Hospitalar do Porto - Hospital Santo António, Porto, Portugal., Prince D; HI - Haemochromatosis International, London, UK.; Haemochromatosis Australia, Meridan Plains, Australia., Ryan J; Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK., Sanchez M; Asociación Española de Hemocromatosis, Santa Coloma, Spain., Santos P; HI - Haemochromatosis International, London, UK. paulo.caleb@unifesp.br.; Department of Pharmacology, Universidade Federal de Sao Paulo, São Paulo, Brazil. paulo.caleb@unifesp.br.; Laboratory of Genetics and Molecular Cardiology, Heart Institute (InCor), University of São Paulo Medical School, 03 de Maio St. INFAR, 4° andar - Vila Clementino, São Paulo, SP, Brazil. paulo.caleb@unifesp.br., Swinkels D; Department of Laboratory Medicine, Radboudumc, Nijmegen, The Netherlands., Teixeira E; HI - Haemochromatosis International, London, UK.; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; FCUP - Faculdade de Ciências da Universidade do Porto, Porto, Portugal.; APH - Associação Portuguesa de Hemocromatose, Porto, Portugal., Toska K; HI - Haemochromatosis International, London, UK.; Norwegian Haemochromatosis Association, Bergen, Norway., Vanclooster A; University Hospitals Leuven, Gasthuisberg, Louvain, Belgium.; Haemochromatose Vereniging Vlaanderen, Leuven, Belgium., White D; HI - Haemochromatosis International, London, UK.; University of Plymouth, Plymouth, UK.

Publikováno v: Hepatology international [Hepatol Int] 2018 Mar; Vol. 12 (2), pp. 83-86. Date of Electronic Publication: 2018 Mar 27.